{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:06:25Z","timestamp":1793642785943,"version":"4.5.1"},"reference-count":35,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Mater Misericordiae Gastrointestinal Research Fund"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2025,7,22]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Fontan-associated liver disease (FALD) results from haemodynamic changes following the Fontan procedure for congenital heart disease and is associated with poorer outcomes. The prevalence of Fontan is rising due to improved survival; however, little is known about predictors of advanced liver fibrosis in adult patients. This study aimed to determine the accuracy of non-invasive fibrosis assessment tools (NIT) in predicting histologically confirmed advanced liver fibrosis in an adult Fontan cohort attending Mater Misericordiae University Hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patient demographics, congenital cardiac variables and fibrosis biomarkers were recorded including liver stiffness measurement (LSM) via transient elastography, Fibrosis-4 (FIB-4) and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) scores. Biopsies, taken between 2017 and 2024, were staged using the congestive hepatic fibrosis score. Analysis was performed using SPSS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>71 patients (58% male) were included. The median age was 25 years. 62% had histological advanced fibrosis. There were no significant bleeding events post biopsy. Overall, advanced fibrosis was associated with a closed Fontan fenestration (p=0.022) and higher LSM, although with a weak correlation (p=0.04, r=0.25, area under the curve (AUC) 0.65), but not with APRI or FIB-4. There was no difference in rates of advanced fibrosis between sex (p=0.84). In females, higher APRI was associated with advanced fibrosis (p=0.045, r=0.41, AUC 0.73).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The majority of Fontan patients have advanced liver fibrosis in their third decade. A patent Fontan fenestration appears to reduce the risk of advanced fibrosis. Despite an association with higher LSM, there was no cut-off which could negate the need for biopsy in a significant population. Our data suggest that the discriminatory ability of NIT may vary according to sex. Liver biopsy is safe and remains the only method of reliably diagnosing advanced fibrosis in FALD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2024-001733","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T18:20:11Z","timestamp":1754418011000},"page":"e001733","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Non-invasive fibrosis tools lack clinical utility for identifying advanced fibrosis in Fontan-associated liver disease: a retrospective cohort study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7520-9050","authenticated-orcid":false,"given":"Paul","family":"Armstrong","sequence":"first","affiliation":[{"name":"The Liver Centre, Mater Misericordiae University Hospital, Dublin, Ireland"},{"name":"School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Moriarty","sequence":"additional","affiliation":[{"name":"The Liver Centre, Mater Misericordiae University Hospital, Dublin, Ireland"},{"name":"School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hughes","sequence":"additional","affiliation":[{"name":"The Liver Centre, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Mehigan","sequence":"additional","affiliation":[{"name":"The Liver Centre, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhona","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Walsh","sequence":"additional","affiliation":[{"name":"School of Medicine, University College Dublin, Dublin, Ireland"},{"name":"Department of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Russell","sequence":"additional","affiliation":[{"name":"The Liver Centre, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Stewart","sequence":"additional","affiliation":[{"name":"The Liver Centre, Mater Misericordiae University Hospital, Dublin, Ireland"},{"name":"School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"2026010701053223000_12.1.e001733.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2019.02.016"},{"key":"2026010701053223000_12.1.e001733.2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s12325-021-02002-3","article-title":"The epidemiology of persons living with Fontan in 2020 and projections for 2030: development of an epidemiology model providing multinational estimates","volume":"39","author":"Plappert","year":"2022","journal-title":"Adv Ther"},{"key":"2026010701053223000_12.1.e001733.3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jtcvs.2016.10.060","article-title":"Liver health in adults with Fontan circulation: a multicenter cross-sectional study","volume":"153","author":"Wu","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026010701053223000_12.1.e001733.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.045597"},{"key":"2026010701053223000_12.1.e001733.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.01.993"},{"key":"2026010701053223000_12.1.e001733.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.06.008"},{"key":"2026010701053223000_12.1.e001733.7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1067\/j.cpradiol.2017.04.002","article-title":"Abdominal imaging surveillance in adult patients after fontan procedure: risk of chronic liver disease and hepatocellular carcinoma","volume":"47","author":"Nandwana","year":"2018","journal-title":"Curr Probl Diagn Radiol"},{"key":"2026010701053223000_12.1.e001733.8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/HEP.0000000000000528","article-title":"Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis","volume":"79","author":"Narasimman","year":"2024","journal-title":"Hepatology"},{"key":"2026010701053223000_12.1.e001733.9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321040"},{"key":"2026010701053223000_12.1.e001733.10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/apt.17952","article-title":"Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation","volume":"59","author":"Hitawala","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"2026010701053223000_12.1.e001733.11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/hepr.13582","article-title":"Hepatocellular carcinoma after Fontan surgery: a systematic review","volume":"51","author":"Rodriguez De Santiago","year":"2021","journal-title":"Hepatol Res"},{"key":"2026010701053223000_12.1.e001733.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.12.033"},{"key":"2026010701053223000_12.1.e001733.13","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jhep.2023.07.013","article-title":"EASL-ERN position paper on liver involvement in patients with Fontan-type circulation","volume":"79","author":"T\u00e9llez","year":"2023","journal-title":"J Hepatol"},{"key":"2026010701053223000_12.1.e001733.14","doi-asserted-by":"crossref","unstructured":"Seol JH , Song J , Kim SJ , et al . Clinical predictors and noninvasive imaging in Fontan-associated liver disease: a systematic review and meta-analysis. Hepatol Commun 2024;8. doi:10.1097\/HC9.0000000000000580","DOI":"10.1097\/HC9.0000000000000580"},{"key":"2026010701053223000_12.1.e001733.15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100362","article-title":"Non-invasive biomarkers of Fontan-associated liver disease","volume":"3","author":"Emamaullee","year":"2021","journal-title":"JHEP Rep"},{"key":"2026010701053223000_12.1.e001733.16","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/eurheartj\/ehy620","article-title":"The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort","volume":"40","author":"Munsterman","year":"2019","journal-title":"Eur Heart J"},{"key":"2026010701053223000_12.1.e001733.17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004809","article-title":"Hepatic fibrosis is universal following fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study","volume":"6","author":"Goldberg","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026010701053223000_12.1.e001733.18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00246-018-1966-9","article-title":"Surveillance testing and preventive care after fontan operation: a multi-institutional survey","volume":"40","author":"Di Maria","year":"2019","journal-title":"Pediatr Cardiol"},{"key":"2026010701053223000_12.1.e001733.19","doi-asserted-by":"publisher","DOI":"10.1161\/hc0202.102237"},{"key":"2026010701053223000_12.1.e001733.20","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s00380-021-01798-y","article-title":"Optimal criteria for transcatheter closure of Fontan fenestration: a single-center experience with a review of literature","volume":"36","author":"Kawasaki","year":"2021","journal-title":"Heart Vessels"},{"key":"2026010701053223000_12.1.e001733.21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1536\/ihj.20-059","article-title":"Risk factors for mid-term liver disease after the Fontan procedure","volume":"61","author":"Oka","year":"2020","journal-title":"Int Heart J"},{"key":"2026010701053223000_12.1.e001733.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.03.312"},{"key":"2026010701053223000_12.1.e001733.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.03.058"},{"key":"2026010701053223000_12.1.e001733.24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101254","article-title":"High-performing fontan patients: a fontan outcome registry by cardiac magnetic resonance imaging study","volume":"3","author":"Alsaied","year":"2024","journal-title":"JACC Adv"},{"key":"2026010701053223000_12.1.e001733.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-012-0315-7"},{"key":"2026010701053223000_12.1.e001733.26","doi-asserted-by":"publisher","DOI":"10.1111\/chd.12159"},{"key":"2026010701053223000_12.1.e001733.27","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/09537104.2014.925104","article-title":"Thrombocytopenia in congenital heart disease patients","volume":"26","author":"Mart\u00ednez-Quintana","year":"2015","journal-title":"Platelets"},{"key":"2026010701053223000_12.1.e001733.28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/CIRCULATIONAHA.124.069779","article-title":"Influence of sex, race and ethnicity, and deprivation on survival and completion of the fontan pathway for children with functionally single ventricle heart disease","volume":"150","author":"Knowles","year":"2024","journal-title":"Circulation"},{"key":"2026010701053223000_12.1.e001733.29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.ijo.0803117","article-title":"Body mass index of healthy men compared with healthy women in the United States","volume":"30","author":"Flegal","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"2026010701053223000_12.1.e001733.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225771","article-title":"Gender-based differences in platelet function and platelet reactivity to P2Y12 inhibitors","volume":"14","author":"Ranucci","year":"2019","journal-title":"PLoS One"},{"key":"2026010701053223000_12.1.e001733.31","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1111\/jocs.16880","article-title":"Hepatic fibrosis gender differences in extracardiac Fontan patients","volume":"37","author":"Evans","year":"2022","journal-title":"J Card Surg"},{"key":"2026010701053223000_12.1.e001733.32","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivw186"},{"key":"2026010701053223000_12.1.e001733.33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26631"},{"key":"2026010701053223000_12.1.e001733.34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jtcvs.2021.12.028","article-title":"Noninvasive surrogates are poor predictors of liver fibrosis in patients with Fontan circulation","volume":"164","author":"Shin","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026010701053223000_12.1.e001733.35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.healun.2016.07.011","article-title":"Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients","volume":"36","author":"Wu","year":"2017","journal-title":"J Heart Lung Transplant"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2024-001733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:06:06Z","timestamp":1767776766000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2024-001733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,8,5]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjgast-2024-001733"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2024-001733","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}